|
|
Monitoring
Essentials for International
Medical Device Trials
Helen Colquhoun, MD
CEO Pleiad Devices
Purchase
recording - US$199
|
 |
Purchase
a recording of this Audio Conference
The
warning letters published on the FDA website have been increasingly
concerned with the monitoring of medical device clinical studies.
It is clear that some device manufacturers are finding it difficult
to comply with the FDA's current guidance and regulations governing
the monitoring of device trials. In Europe, monitoring standards
are similar but there is often a lack of clarity of what is expected
because the audience for the clinical trial application (the competent
authorities) and the CE marking dossier (the Notified Bodies)
is different.
In
this presentation, Dr. Helen Colquhoun will summarize the regulations
and official guidance governing the monitoring of medical device
clinical trials in the USA and EU. She will also provide the audience
with the essentials necessary to ensure compliance with these
regulations, including giving practical examples of what monitors
need to do at site. Dr. Colquhoun will also cover how to deal
with difficult investigators and sites that are unwilling to comply
with regulatory standards. The presentation will also look at
the consequences of non-compliance, and how to prepare for a monitoring
audit by the FDA. Helen will also discuss how clinical research
departments need to be resourced to deal adequately with monitoring
demands.
This
audio conference will cover:
- The current
regulations governing the monitoring of medical device clinical
trials in the USA and EU
- What monitors
need to do at site to ensure compliance with these regulations
- The implications
for trial sponsors of non-compliance
- How to
prepare for an FDA monitoring audit
- How to
staff clinical research departments to adequately monitor studies
About
the speaker:
Helen
Colquhoun, MD holds degrees in Genetics and Medicine from the
University of Edinburgh and spent several years practicing clinical
medicine before entering the life science industry in 1988. Initially
working in the UK in the pharmaceutical industry, Helen set up
as an independent consultant in 1995. Since that time she has
spent increasingly more time working with medical device and drug
delivery companies. In 2000 she co-founded the Pleiad group of
companies and is currently CEO of Pleiad Devices, a clinical research
organization based in the USA and Europe that specializes in clinical
research and regulatory support for medical device companies.
Helen runs Pleiad's North American operation and is based in Cambridge,
Massachusetts.
Who should
attend?
- Clinical
Research Managers
- Clinical
Research Associates
- Clinical
Research Monitors
- Regulatory
and Compliance Department Managers
- Regulatory
and Compliance Associates
Purchase
Options:
|